https://panajotovikj.com/blog/2026/02/01/signal-detection-in-pharmacovigilance/ 2026-02-01T00:00:00+00:00 https://panajotovikj.com/blog/2026/02/12/when-drug-safety-LLMs-stop-being-demos-and-start-becoming-infrastructure/ 2026-02-12T00:00:00+00:00 https://panajotovikj.com/blog/2026/03/10/why-rag-matters-more-than-model-size-in-pharmacovigilance/ 2026-03-10T00:00:00+00:00 https://panajotovikj.com/blog/2026/03/23/artificial-intelligence-and-large-language-models-in-drug-safety/ 2026-03-23T00:00:00+00:00 https://panajotovikj.com/blog/2026/03/27/diabetes-drug-affects-brain/ 2026-03-27T00:00:00+00:00 https://panajotovikj.com/blog/2026/04/07/spontaneous-reporting-systems/ 2026-04-07T00:00:00+00:00 https://panajotovikj.com/blog/2026/04/14/benchmarking-signal-detection-the-reference-set-problem/ 2026-04-14T00:00:00+00:00 https://panajotovikj.com/blog/2026/04/20/pediatric-pharmacovigilance/ 2026-04-20T00:00:00+00:00 https://panajotovikj.com/blog/2026/04/26/stimulated-reporting-weber-effects-and-disproportionality/ 2026-04-26T00:00:00+00:00 https://panajotovikj.com/blog/2026/05/06/can-llms-detect-negation-reliably-in-safety-narratives/ 2026-05-06T00:00:00+00:00 https://panajotovikj.com/blog/ https://panajotovikj.com/cv/ https://panajotovikj.com/ https://panajotovikj.com/reserach/ai-text-detection/P19-3019.pdf 2026-05-06T13:50:09+00:00